Differential Effects of Acetylcholinesterase Inhibitors on Clinical Responses and Cerebral Blood Flow Changes in Patients with Alzheimer's Disease: A 12-Month, Randomized, and Open-Label Trial

Differential Effects of Acetylcholinesterase Inhibitors on Clinical Responses and Cerebral Blood Flow Changes in Patients with Alzheimer's Disease: A 12-Month, Randomized, and Open-Label Trial

Background/Aims: The present study evaluated the differences in treatment outcomes and brain perfusion changes among 3 types of acetylcholinesterase inhibitors (AchEIs, i.e. donepezil, rivastigmine, and galantamine). Methods: This was a prospective, longitudinal, randomized, open-label, 3-arm (donep...

Full description

Bibliographic Details
Main Authors: Soichiro Shimizu, Hidekazu Kanetaka, Daisuke Hirose, Hirohumi Sakurai, Haruo Hanyu
Format: Article
Language:English
Published: Karger Publishers 2015-04-01
Series:Dementia and Geriatric Cognitive Disorders Extra
Subjects:
Acetylcholinesterase inhibitors
Donepezil
Rivastigmine
Galantamine
Regional cerebral blood flow
Single-photon emission computed tomography
Alzheimerߣs disease
Online Access:http://www.karger.com/Article/FullText/375527

Internet

http://www.karger.com/Article/FullText/375527

Similar Items